Prolonged NOACs beat warfarin for lowering recurrent VTE risk: study
Patients prescribed extended anticoagulation for VTE have a lower risk of recurrent VTE with NOACs compared to warfarin, according to a study in JAMA Network…
Specialist Updates
In-depth coverage of specialist medicine
Exposure to cardiotoxic cancer drugs ‘substantial and growing’, Aussie study shows
The number of patients exposed to potentially cardiotoxic cancer medicines quadrupled over the past two decades and is projected to continue rising, Australian researchers report. …
Bronchial thermoplasty ‘highly effective’ for long-term severe asthma control
Nearly half of adults with severe asthma taking maintenance oral steroids were able to completely cease treatment within six months of bronchial thermoplasty, Australian doctors…
Most infant RSV cases in intensive care ‘previously healthy and delivered full-term’
Most infants requiring intensive care for respiratory syncytial virus are born at term and do not have underlying medical conditions, according to a study in…
Aussie-first study confirms endometriosis link to range of non-menstrual symptoms
Women with endometriosis are nearly four times more likely to have severe menstrual pain than those without the condition, along with a host of non-menstrual…
RAAS blockade ‘boosts survival’ post-SAVR: study
Prolonged use of RAAS inhibitors may lead to better survival after surgical aortic valve replacement in patients with severe aortic stenosis, a population-based study shows.…
Deceased organ donors a ‘feasible’ option for uterus transplants
Future demand for donor uterus transplants to treat uterine infertility could be met through existing deceased organ and tissue donation programs, according to new research.…
Antidepressant use tied to greater risk of pneumonia, COPD exacerbations: study
Adults with COPD who are prescribed antidepressants may need close monitoring for side effects, say UK researchers who found an increased risk of pneumonia and…
Which antiplatelet monotherapy is best for CAD secondary prevention?
Antiplatelet monotherapy with clopidogrel or ticagrelor may be safer and more effective for secondary prevention of cardiovascular events than aspirin alone, results from a large…
1 in 4 patients die within a year of first HF hospitalisation: study
Globally, one in four patients die within 12 months of their first heart failure-related hospitalisation, according to a study in JACC: Heart Failure. Dr Biykem…
